Globus Medical
An American orthopedic medical-device company focused on implants, instruments, navigation, and robotic technologies for musculoskeletal surgery.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Globus Medical is an American orthopedic medical-device company established in 2003 and headquartered in Audubon, Pennsylvania. Its business centers on the design, development, manufacture, and commercialization of products intended to help surgeons treat musculoskeletal disorders. The company is particularly associated with spine surgery, where it supplies implants, fixation systems, surgical instruments, planning software, navigation technologies, and robotic platforms. Its portfolio also extends into trauma and extremity procedures, biologic and allograft-related products, and artificial joints for hip and knee replacement. The company’s spine portfolio includes interbody fusion products, pedicle-screw and rod systems, plates, deformity solutions, and instruments used in procedures addressing spinal degeneration, instability, deformity, and trauma. A major area of differentiation is the integration of implants with digital planning, intraoperative imaging, navigation, and robotic assistance. Its ExcelsiusGPS platform is designed to support spinal procedures including transpedicular drilling and screw placement, with the robotic system intended to improve procedural planning and instrument positioning. In November 2024, Globus Medical introduced ExcelsiusHub, an advanced navigation system intended for robotic surgical procedures and designed to complement the company’s digital surgery ecosystem. Globus expanded beyond a primarily spine-focused identity through acquisitions and internal product development. In 2014 it acquired Excelsius Surgical, bringing into the company the technology that became the foundation for its robotic spine-surgery activities. It also acquired Transplant Technologies of Texas, a processor and supplier of human tissue products, and later added manufacturing, distribution, software-planning, and joint-replacement capabilities through additional transactions. These moves broadened Globus Medical’s reach across the orthopedic value chain, from preoperative planning and intraoperative assistance to implants, instruments, biologic materials, and manufacturing. The company became publicly traded on the New York Stock Exchange in 2012 under the symbol GMED. Its 2023 all-stock acquisition of NuVasive significantly increased the combined company’s scale in spine technology, surgical products, and international commercial operations. Globus Medical therefore operates as both a product brand and a broader orthopedic-device platform, serving hospitals, surgeons, and healthcare systems through direct and international channels. Its positioning is centered on surgeon-oriented innovation, procedural integration, and a broad musculoskeletal surgery offering rather than on consumer healthcare products.
History
Globus Medical was established in 2003 in the United States as an orthopedic medical-device company with a strong emphasis on spine surgery. From its early development, the company’s commercial model focused on supplying surgeons with implants and instruments used in procedures for spinal disorders and deformities. Its core product categories included spinal fusion cages, fixation systems, and pedicle-screw constructs. Rather than limiting itself to a single implant technology, Globus pursued a broader procedural portfolio combining implants, instruments, and technologies intended to support the complete surgical workflow. The company became publicly traded on the New York Stock Exchange in 2012 under the ticker GMED. Before and after its public listing, Globus faced legal scrutiny related to intellectual property and competition. In 2007 it settled litigation initiated by Synthes concerning allegations that former Synthes employees who joined Globus had taken electronic files containing product blueprints, testing plans, and regulatory filing materials. Globus paid $13.5 million without admitting wrongdoing. Synthes later filed another action alleging infringement of three patents; a monetary payment of approximately $16 million was reported in 2013, with no finding of willful infringement reported in connection with that case. A major strategic turning point came in 2014, when Globus acquired Excelsius Surgical. The acquired technology integrated intraoperative imaging with a robotic device intended to assist with patient positioning and surgical execution. This transaction became the foundation for the ExcelsiusGPS robotic platform, which supports spine procedures such as transpedicular drilling and screw placement. In the same year, Globus expanded into human tissue products through the acquisition of Transplant Technologies of Texas. That business supplied bone allografts, biomaterials, and soft-tissue products for several clinical markets, including spine, orthopedics, sports medicine, dental care, and wound care. Globus continued to build internal manufacturing and commercial capabilities. In 2015 it acquired Branch Medical Group, a precision medical-device manufacturer. In 2016 it acquired Alphatec Holdings’ international operations and distribution channel for $80 million, while also agreeing to provide a senior secured credit facility of up to $30 million over five years. The move increased Globus’s international distribution reach. In 2018 the company acquired Nemaris, developer of Surgimap, adding preoperative planning software for spinal surgeons. In 2019 it acquired StelKast, extending the company into implants and instruments for hip and knee replacement. The company’s product strategy increasingly connected implants with software, navigation, imaging, and robotics. ExcelsiusGPS became a prominent expression of that approach, helping position Globus as a technology-oriented spine company rather than only an implant supplier. Its portfolio also broadened into trauma, artificial joints, biologic materials, and related instruments. The ADIRA XLIF Plate System supported lateral spine procedures, illustrating the company’s continued emphasis on procedure-specific solutions. In February 2023, Globus Medical acquired NuVasive in an all-stock transaction valued at approximately $3.1 billion. The combination enlarged the company’s spine portfolio, global commercial presence, and technology base. In November 2024, Globus launched ExcelsiusHub, an advanced navigation system for robotic procedures, further developing its digital-surgery ecosystem. Globus Medical remains an active public orthopedic-device company headquartered in Audubon, Pennsylvania, with operations serving United States and international markets.
- 2024
ExcelsiusHub launch
[1]Globus introduced ExcelsiusHub as an advanced navigation system for robotic surgical procedures.
- 2023
NuVasive acquisition
[1]Globus Medical completed an all-stock acquisition of NuVasive valued at approximately $3.1 billion.
- 2019
Expansion into hip and knee reconstruction
[1]The acquisition of StelKast added hip and knee replacement implants and instruments.
- 2018
Addition of Surgimap planning software
[1]The acquisition of Nemaris added Surgimap, a preoperative planning platform for spine surgeons.
- 2014
Entry into robotic spine surgery
[1]The acquisition of Excelsius Surgical provided technology that supported development of the ExcelsiusGPS robotic spine-surgery platform.
- 2014
Expansion into human tissue products
[1]Globus acquired Transplant Technologies of Texas and expanded into allografts, biomaterials, and soft-tissue products.
- 2012
New York Stock Exchange listing
[1]Globus Medical became publicly traded on the New York Stock Exchange under the symbol GMED.
- 2007
Settlement of Synthes trade-secret case
[1]Globus settled litigation brought by Synthes concerning alleged use of confidential electronic files and paid $13.5 million without admitting wrongdoing.
- 2003
Company established
[1]Globus Medical was established as an orthopedic medical-device company focused substantially on spine surgery.
Products and positioning
A technology-oriented orthopedic medical-device brand with a strong spine-surgery focus and an expanding platform spanning implants, instruments, biologics, planning software, navigation, robotics, trauma, and joint reconstruction.
Robotic spine-surgery system
ExcelsiusGPS
ExcelsiusGPS is Globus Medical’s robotic platform for spine surgery. It is designed to integrate digital imaging and robotic assistance during procedures, including transpedicular drilling and screw placement. The system represents the company’s strategy of combining implants with navigation and intraoperative technologies to support planning, positioning, and execution of spinal procedures.
Surgical navigation system · 2024
ExcelsiusHub
ExcelsiusHub is an advanced navigation system introduced in November 2024 for robotic surgical procedures. It extends Globus Medical’s Excelsius digital-surgery ecosystem by providing navigation capabilities intended to support image-guided and robot-assisted workflows.
Spine implants
Spinal fusion systems
Globus Medical develops spinal fusion products including interbody cages, fixation constructs, plates, and associated instruments. These products are used in procedures intended to stabilize the spine and promote fusion in patients with degenerative conditions, deformity, instability, or trauma.
Spine implants and instruments
Pedicle-screw fixation systems
The company’s pedicle-screw and rod systems provide fixation solutions for spinal stabilization and deformity procedures. They are part of Globus Medical’s core spine portfolio and are designed to be used with the company’s procedural instruments and, where applicable, navigation and robotic technologies.
Lateral spine-surgery implant system
ADIRA XLIF Plate System
The ADIRA XLIF Plate System is intended to support lateral lumbar interbody fusion procedures. It provides plating for lateral spine surgery and illustrates Globus Medical’s development of procedure-specific implant solutions alongside its broader fusion and fixation portfolio.
Spine-planning software
Surgimap
Surgimap is preoperative planning software for spine surgeons. Globus Medical added the platform through its 2018 acquisition of Nemaris, expanding the company’s capabilities in digital planning and connecting software-based planning with its implant, navigation, and robotic-surgery offerings.
Orthopedic trauma products
Trauma implants and instruments
Globus Medical’s orthopedic portfolio includes implants and instruments for trauma applications. These products broaden the company beyond elective spine procedures and serve musculoskeletal surgery workflows requiring fixation and reconstruction after injury.
Joint reconstruction · 2019
Hip and knee replacement products
Through its acquisition of StelKast, Globus Medical expanded into implants and instruments used in hip and knee replacement. This line gives the company a presence in artificial-joint reconstruction alongside its established spine, trauma, biologics, and surgical-technology businesses.
Orthopedic biologics · 2014
Human tissue and allograft products
Globus Medical added human tissue products through Transplant Technologies of Texas. The portfolio includes bone allografts, biomaterials, and soft-tissue products serving spine, orthopedic, sports-medicine, dental, and wound-care markets.
Controversies
2011
Synthes patent-infringement lawsuit
Synthes filed a separate lawsuit alleging that Globus Medical infringed three patents and sought remedies involving the disputed products. The reported outcome included approximately $16 million in monetary damages in 2013; available reporting indicated no finding of willful infringement.
2007
Synthes trade-secret litigation
Synthes alleged that former employees who joined Globus Medical had taken thousands of electronic files containing product blueprints, safety-testing plans, and regulatory filing materials. Globus settled the case for $13.5 million and did not admit wrongdoing.
Brand decisions
2024
Launch ExcelsiusHubProduct launchBackground
Globus Medical continued developing an integrated digital and robotic-surgery ecosystem for spine procedures.
Action taken
The company launched ExcelsiusHub as an advanced navigation system for robotic surgical procedures.
Aftermath
ExcelsiusHub expanded the company’s navigation offering and complemented its ExcelsiusGPS robotic platform.
2023
Acquire NuVasiveM&ABackground
Globus Medical pursued greater scale in spine technology, products, and international operations.
Action taken
The company acquired NuVasive in an all-stock transaction.
Aftermath
The transaction created a larger orthopedic and spine-surgery platform combining the companies’ product portfolios and commercial capabilities.
Transaction value. $3.1 billion (2023)
2016
Acquire Alphatec international operationsM&ABackground
Globus Medical aimed to increase its international commercial and distribution capabilities.
Action taken
Globus acquired Alphatec Holdings’ international operations and distribution channel for $80 million and agreed to provide a senior secured credit facility of up to $30 million for five years.
Aftermath
The transaction expanded Globus Medical’s international operating and distribution platform.
Acquisition price. $80 million (2016)
2014
Acquire Excelsius SurgicalM&ABackground
Globus Medical sought to expand from conventional implants and instruments into image-guided and robotic spine surgery.
Action taken
The company acquired Excelsius Surgical and incorporated its robotic-surgery technology into Globus Medical’s product-development strategy.
Aftermath
The transaction supported development of the ExcelsiusGPS robotic spine-surgery platform.
Recent events
- 2024
Globus Medical launches ExcelsiusHub[1]
Product launch · Product generation
The company introduced ExcelsiusHub, an advanced surgical-navigation system intended to support robotic surgical procedures and broaden its connected digital-surgery offering.
- 2023
Globus Medical announces all-stock acquisition of NuVasive[1]
M&A
Globus Medical acquired NuVasive in an all-stock transaction valued at approximately $3.1 billion, creating a larger spine-technology and orthopedic-device platform.
- 2019
Globus Medical acquires StelKast[1]
M&A
Globus acquired privately held StelKast, a manufacturer of implants and instruments for hip and knee replacement, strengthening its position beyond spine surgery.
- 2018
Globus Medical acquires Nemaris and Surgimap technology[1]
M&A · Product generation
The acquisition added Nemaris, developer of Surgimap, a software platform used by spine surgeons for preoperative planning.
- 2016
Globus Medical acquires Alphatec’s international operations and distribution channel[1]
M&A
Globus Medical acquired Alphatec Holdings’ international operations and distribution channel for $80 million. The transaction also included an agreement to provide Alphatec with a five-year senior secured credit facility of up to $30 million.
- 2015
Globus Medical acquires Branch Medical Group[1]
M&A
The acquisition added a third-party manufacturer specializing in high-precision medical devices and expanded Globus Medical’s manufacturing capabilities.
- 2014
Globus Medical acquires Excelsius Surgical[1]
M&A · Product generation
The acquisition brought Excelsius Surgical’s robotic-surgery technology into Globus Medical and supported the company’s later development of the ExcelsiusGPS spine-surgery platform.
- 2014
Globus Medical acquires Transplant Technologies of Texas[1]
M&A
Globus acquired a tissue-processing business supplying human tissue products, including bone allografts, biomaterials, and soft-tissue products for spine, orthopedic, sports-medicine, dental, and wound-care applications.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/globus-medical · Editorial policy · How profiles are compiled